Editorial: Integrating transcriptional modulation in systemic tumor therapy
- PMID: 38482207
- PMCID: PMC10933090
- DOI: 10.3389/fonc.2024.1385766
Editorial: Integrating transcriptional modulation in systemic tumor therapy
Keywords: all-trans retinoic acid; anakoinosis; dexamethasone; interferon-α; low dose metronomic chemotherapy; phenotypic plasticity; pioglitazone; tumor tissue editing.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision
Figures
Comment on
- Editorial on the Research Topic Integrating transcriptional modulation in systemic tumor therapy
References
-
- Clarisse D, Prekovic S, Vlummens P, Staessens E, van Wesemael K, Thommis J, et al. . Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells. Cell Mol Life Sci. (2023) 80:249. doi: 10.1007/s00018-023-04900-x - DOI - PMC - PubMed
-
- Muqaku B, Eisinger M, Meier SM, Tahir A, Pukrop T, Haferkamp S, et al. . Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma. Mol Cell Proteomics. (2017) 16:86–99. doi: 10.1074/mcp.M116.063313 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
